The Sixth China Healthcare Summit is the leading international forum to discuss how China is building the bridge to global healthcare. Dr Sarah Howell will address how UK Biopharmaceutical companies such as Arecor can collaborate with the growing innovative Chinese biotech ecosystem and investment community.  Her presentation will focus on Arecor’s Arestat™ technology platform’s ability to develop superior biopharmaceuticals through the innovative reformulation of proteins and peptides, enabling the advancement of current treatments for diabetes and other conditions.